Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
$5M philanthropic gift to the Kirby Institute from The Glendonbrook Foundation
The Kirby Institute at UNSW Sydney will establish a national program to significantly reduce the…
Marker discovered which shows when cutaneous squamous cell carcinoma is preparing to metastasise
Cells that form cutaneous squamous cell carcinoma tumours prepare themselves to migrate to the lymph…
Goodbye ‘Dr Google’ as ChatGPT set to change cancer patient information
Public access to sophisticated next-generation AI programs, led by ChatGPT, is opening the way to…
Novel nanoparticle enhances radiation tumour killing
Radiation kills tumours by creating oxygen free radicals that damage the tumour DNA. However, the lack of oxygen in the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.